![Raffaele Baffa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Raffaele Baffa
Technik-/Wissenschafts-/F&E-Leiter bei CARSGEN THERAPEUTICS HOLDINGS LIMITED
Profil
Raffaele Baffa's career history includes current and former positions as well as education.
Currently, he is the Chief Medical Officer at CARsgen Therapeutics Holdings Ltd.
Previously, he held positions such as Director-Urology Research at Genito Urinary Medical Oncologists of Canada Gumo, Head-Translational Sciences at Sanofi, Inc., Vice President at Shire Pharmaceuticals LLC, Chief Medical Officer at Servier Pharmaceuticals LLC, and Chief Medical Officer at Alaunos Therapeutics, Inc. He also served as the Chief Medical Officer at Medisix Therapeutics, Inc. Dr. Baffa's education includes a doctorate from Providence College & Theological Seminary and the University of Parma.
Aktive Positionen von Raffaele Baffa
Unternehmen | Position | Beginn |
---|---|---|
CARSGEN THERAPEUTICS HOLDINGS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 07.04.2022 |
Ehemalige bekannte Positionen von Raffaele Baffa
Unternehmen | Position | Ende |
---|---|---|
ALAUNOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2022 |
Servier Pharmaceuticals LLC
![]() Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company, based in Boston, MA, was founded in 1954. Servier Pharmaceuticals is committed to innovation and improving the lives of patients, their families, and caregivers. The company invests in research and development to address the unmet needs of patients, particularly in the areas of oncology, cardiovascular diseases, cancers, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. The company offers financial assistance to support patients, advocacy groups, and healthcare professionals. The company strives for transparency in clinical trials and research and development. Servier Pharmaceuticals aims to create a brighter future for all by providing life-saving treatments to a greater number of patients. The company actively seeks alliances, acquisitions, licensing deals, and partnerships to accelerate access to therapies. David K. Lee has been the CEO of the company since 2018. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2020 |
Shire Pharmaceuticals LLC
![]() Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Corporate Officer/Principal | 01.09.2018 |
Sanofi, Inc.
![]() Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Corporate Officer/Principal | 01.02.2018 |
Genito Urinary Medical Oncologists of Canada Gumo | Corporate Officer/Principal | - |
Ausbildung von Raffaele Baffa
Providence College & Theological Seminary | Doctorate Degree |
University of Parma | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ALAUNOS THERAPEUTICS, INC. | Health Technology |
CARSGEN THERAPEUTICS HOLDINGS LIMITED | Health Technology |
Private Unternehmen | 5 |
---|---|
Sanofi, Inc.
![]() Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
Shire Pharmaceuticals LLC
![]() Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Health Technology |
Servier Pharmaceuticals LLC
![]() Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company, based in Boston, MA, was founded in 1954. Servier Pharmaceuticals is committed to innovation and improving the lives of patients, their families, and caregivers. The company invests in research and development to address the unmet needs of patients, particularly in the areas of oncology, cardiovascular diseases, cancers, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. The company offers financial assistance to support patients, advocacy groups, and healthcare professionals. The company strives for transparency in clinical trials and research and development. Servier Pharmaceuticals aims to create a brighter future for all by providing life-saving treatments to a greater number of patients. The company actively seeks alliances, acquisitions, licensing deals, and partnerships to accelerate access to therapies. David K. Lee has been the CEO of the company since 2018. | Health Technology |
Medisix Therapeutics, Inc.
![]() Medisix Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Medisix Therapeutics, Inc. develops novel cellular therapies to address T cell malignancies. The company is headquartered in Singapore. | Commercial Services |
Genito Urinary Medical Oncologists of Canada Gumo |